These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 7705584)
21. [Incidence of hepatitis B, C and D infection in chronic liver diseases]. Horváth G; Tolvaj G; Dávid K Orv Hetil; 1992 Sep; 133(39):2475-80. PubMed ID: 1408083 [TBL] [Abstract][Full Text] [Related]
22. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782 [TBL] [Abstract][Full Text] [Related]
23. [The role of the hepatitis B, C and D viruses in the etiology of chronic hepatopathies in Cluj]. Neamţu A; Pascu O; Szanto P; Chira O; Neamţu D; State D Bacteriol Virusol Parazitol Epidemiol; 1995; 40(2):119-23. PubMed ID: 7549253 [TBL] [Abstract][Full Text] [Related]
24. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices. Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study. Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010 [TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus infections in oral and injectable drug users. Woodfield DG; Harness M; Rix-Trott K N Z Med J; 1993 Aug; 106(961):332-4. PubMed ID: 8341473 [TBL] [Abstract][Full Text] [Related]
27. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. Devi KhS; Brajachand N; Singh HL; Singh YM J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization. Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Ninomiya M; Lorenzo FR; Okamoto H J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839 [TBL] [Abstract][Full Text] [Related]
29. [High prevalence of infection by hepatitis B virus and HIV in incarcerated French drug addicts]. Espinoza P; Bouchard I; Buffet C; Thiers V; Pillot J; Etienne JP Gastroenterol Clin Biol; 1987 Apr; 11(4):288-92. PubMed ID: 3582884 [TBL] [Abstract][Full Text] [Related]
30. [Prevalence of liver damage in alcoholics and drug addicts]. Marioni CF; Rapisarda L; Lussetti M; Perseghin P Recenti Prog Med; 1991 Nov; 82(11):577-80. PubMed ID: 1763228 [TBL] [Abstract][Full Text] [Related]
31. [The prevalence of hepatitis C and B viral markers in patients with sexually transmitted diseases in Cluj]. Neamţu A; Cozgarea R; State D; Neamţu D Bacteriol Virusol Parazitol Epidemiol; 1995; 40(2):115-8. PubMed ID: 7549252 [TBL] [Abstract][Full Text] [Related]
32. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus. Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317 [TBL] [Abstract][Full Text] [Related]
33. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia. Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292 [TBL] [Abstract][Full Text] [Related]
34. [Serological markers of selected viral infections transmitted by parenteral route in drug addicts]. Halota W; Opoka J; Trzciński J; Dorau M; Topczewska E; Giziński W; Bulik F Przegl Epidemiol; 1991; 45(4):347-9. PubMed ID: 1668703 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of antibody to hepatitis D virus among HBsAg-positive drug-dependent patients in Jeddah, Saudi Arabia. Njoh J; Zimmo S East Afr Med J; 1998 Jun; 75(6):327-8. PubMed ID: 9803612 [TBL] [Abstract][Full Text] [Related]
36. Antibodies to hepatitis delta virus in intravenous drug addicts and male homosexuals in Spain. León P; López JA; Contreras G; Echevarría JM Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):533-5. PubMed ID: 3141166 [TBL] [Abstract][Full Text] [Related]
37. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia. Maher L; Chant K; Jalaludin B; Sargent P J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287 [TBL] [Abstract][Full Text] [Related]
38. Prevalence and presentation of hepatitis C related chronic liver disease in southern India. Issar SK; Ramakrishna BS; Ramakrishna B; Christopher S; Samuel BU; John TJ J Trop Med Hyg; 1995 Jun; 98(3):161-5. PubMed ID: 7783272 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340 [TBL] [Abstract][Full Text] [Related]
40. [Infection with hepatitis C virus in a prison environment. A prospective study in Loos-lez-Lille, France]. Hedouin V; Gosset D Gastroenterol Clin Biol; 1998 Jan; 22(1):55-8. PubMed ID: 9762167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]